Tumour Disappears In All 12 Rectal Cancer Patients In Rare Medical Trial

A group of 12 rectal cancer patients showed no signs of a tumour after taking an antibody drug for six months, according to a surprise finding from an ongoing medical trial in the US that experts termed optimistic

Zydus Cadila Gets USFDA Green Signal For Cancer Drug With 180 Days Exclusivity

The company has received approval from the US Food and Drug Administration (USFDA) for the Nelarabine injection 250 MG/50ML, a generic version of Arranon injection.

AstraZeneca Bets Up To $6 Billion On New Daiichi Cancer Drug

AstraZeneca has been bolstering its portfolio of cancer therapies, particularly ADCs, a major area of focus for the company as it also ploughs on with its coronavirus vaccine candidate.

Sun Pharma, Israeli Institute Tie Up For Cancer Drug Development

India Reserves Right To Act On Patents

Proposal To Peg Drug Price To Per Capita Income

Cancer Drug: AstraZeneca's Patent Plea Rejected

India Revokes Patent On Merck Asthma Drug

Pfizer To Appeal Decision To Revoke Cancer Drug Patent

Bayer's Plea For Stay On Generic Dismissed

India Partly Revokes Roche Cancer Drug Patent